Nat Commun:病毒也能治脑瘤

2019-05-30 晋楠 中国科学报

《自然—通讯》5月28日发表的一项研究称,一种溶瘤病毒(靶向癌细胞的病毒)有效延长了两种不同类型儿童脑肿瘤模型小鼠的存活时间。这些发现促使研究人员利用该病毒展开一项长期临床试验。

《自然—通讯》5月28日发表的一项研究称,一种溶瘤病毒(靶向癌细胞的病毒)有效延长了两种不同类型儿童脑肿瘤模型小鼠的存活时间。这些发现促使研究人员利用该病毒展开一项长期临床试验。

儿童脑肿瘤如高级别胶质瘤和弥漫内生性脑桥胶质瘤难以治疗,而且与成人肿瘤相比具有遗传差异性。高级别胶质瘤患者的治疗方法是手术、放疗和化疗,但是手术不适合患有弥漫内生性脑桥胶质瘤的儿童患者。美国食品与药物管理局已经批准将溶瘤病毒用于治疗黑素瘤,而且现已表明,Delta-24-RGD病毒对胶质瘤成年患者有效且安全。

西班牙纳瓦拉健康研究所的Marta Alonso及同事利用高级别胶质瘤和弥漫内生性脑桥胶质瘤模型小鼠,检验Delta-24-RGD病毒的有效性。他们发现与未经治疗的小鼠相比,在4种不同癌症模型中,实验小鼠的存活时间延长了。而且在长期存活的小鼠中未检测到病毒蛋白,这意味着这种方法是安全的。

进一步研究表明,病毒在小鼠体内触发了免疫响应,这意味着免疫系统的激活促成了抗癌响应。以上发现表明,这种方法或能用于治疗患有此类肿瘤的儿童患者,但这一点还需要试验验证。

原始出处:

Naiara Martínez-Vélez, Marc Garcia-Moure, Marta M. Alonso, et.al. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Nature Communications 28 May 2019

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1883717, encodeId=d3681883e17ce, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Apr 22 08:30:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087550, encodeId=0e8a208e55000, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Mar 21 12:30:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275711, encodeId=f2ec12e571137, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Sat Jun 01 07:30:00 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367011, encodeId=694136e011d8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu May 30 18:56:47 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367009, encodeId=010136e00936, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 30 18:33:05 CST 2019, time=2019-05-30, status=1, ipAttribution=)]
    2020-04-22 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1883717, encodeId=d3681883e17ce, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Apr 22 08:30:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087550, encodeId=0e8a208e55000, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Mar 21 12:30:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275711, encodeId=f2ec12e571137, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Sat Jun 01 07:30:00 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367011, encodeId=694136e011d8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu May 30 18:56:47 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367009, encodeId=010136e00936, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 30 18:33:05 CST 2019, time=2019-05-30, status=1, ipAttribution=)]
    2020-03-21 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1883717, encodeId=d3681883e17ce, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Apr 22 08:30:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087550, encodeId=0e8a208e55000, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Mar 21 12:30:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275711, encodeId=f2ec12e571137, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Sat Jun 01 07:30:00 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367011, encodeId=694136e011d8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu May 30 18:56:47 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367009, encodeId=010136e00936, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 30 18:33:05 CST 2019, time=2019-05-30, status=1, ipAttribution=)]
    2019-06-01 jxrzshh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1883717, encodeId=d3681883e17ce, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Apr 22 08:30:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087550, encodeId=0e8a208e55000, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Mar 21 12:30:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275711, encodeId=f2ec12e571137, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Sat Jun 01 07:30:00 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367011, encodeId=694136e011d8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu May 30 18:56:47 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367009, encodeId=010136e00936, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 30 18:33:05 CST 2019, time=2019-05-30, status=1, ipAttribution=)]
    2019-05-30 orangesking

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1883717, encodeId=d3681883e17ce, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Apr 22 08:30:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087550, encodeId=0e8a208e55000, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Mar 21 12:30:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275711, encodeId=f2ec12e571137, content=<a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84946, encryptionId=aad38494640, topicName=脑瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Sat Jun 01 07:30:00 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367011, encodeId=694136e011d8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu May 30 18:56:47 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367009, encodeId=010136e00936, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 30 18:33:05 CST 2019, time=2019-05-30, status=1, ipAttribution=)]
    2019-05-30 329523732

    不错

    0

相关资讯

Cell Rep:病毒学国家重点实验室刘昱课题组在抗病毒天然免疫方面取得新进展

近日,病毒学国家重点实验室刘昱教授课题组在国际学术期刊Cell Reports上在线发表了最新研究成果,论文题为“TMED2 potentiates cellular IFN responses to DNA viruses by reinforcing MITA dimerization and facilitating its trafficking”。

Ocul Immunol Inflamm:新发病毒感染导致葡萄膜炎

突尼斯莫纳斯提尔大学医学院Fattouma Bourguiba大学医院眼科的Khairallah M等人近日在Ocul Immunol Inflamm杂志上发表了一项重要的综述文章,他们回顾了与眼科医生相关的特定紧急病毒感染性疾病的系统性和眼部症状,尤其是对葡萄膜炎的研究。

Transgene个性化病毒免疫疗法TG4050,即将开展卵巢癌的临床开发

Transgene宣布获得美国食品和药物管理局(FDA)批准的研究性新药申请(IND),将开展其候选药物TG4050的1期临床试验,用作一线手术和化疗后卵巢癌患者的潜在治疗方案。

Cell:终于等到这一天,科学家发现了流感病毒的致命弱点

未来也许不用每一年都去打流感疫苗了,多年有效的通用性疫苗指日可待。

遗传学大师George Church的“疯狂尝试”:对细胞进行了超13,000次的CRISPR编辑

最初,CRISPR只是细菌体内的一个“免疫机制”,用于防御入侵病毒和外源DNA。随着研究深入,CRISPR被科学家们“化为己用”,基于此实现了基因删除、插入、激活、大片段以及染色体敲除等可能。如今,CRISPR已经成为纠正突变基因、解决器官异种移植关键难题、治疗疑难杂症等领域的热门技术。

Cancer Gene Ther:去势抵抗性前列腺癌细胞中的基因疗法研究

前列腺癌是全球范围内男性的第二大癌症。晚期阶段的前列腺癌患者通常通过雄激素阻断疗法(ADT)来治疗。然而,随着疾病的恶化,常常会发展成为不可治愈的去势抵抗性前列腺癌(CRPC)。JC型多瘤病毒(JCPyV)是一种人类DNA病毒。它的类病毒颗粒(VLPs)展现出了与原生病毒相似的趋向性,并且具有将外源基因转化进靶细胞进行表达的能力。研究人员在前列腺细胞中检测到了JCPyV;因此,前列腺癌细胞可能对J